NGS library prep market seen reaching $5.96 billion by 2030

The market for library preparation and target enrichment products used in next-generation sequencing is projected to grow from $3.43 billion in 2025 to $5.96 billion by 2030, driven by personalized medicine, cancer genomics and broader clinical use. North America led in 2025, while Asia-Pacific is expected to be the fastest-growing region.

Why it matters: - Library preparation and target enrichment products help make next-generation sequencing more accurate, efficient and cost-effective. - The market is tied to personalized medicine, cancer research, rare disease testing and clinical genomics. - The forecast points to sustained demand for tools that support precision diagnostics and targeted sequencing workflows.

What happened: - The Business Research Company released its Library Preparation And Target Enrichment For Next-Generation Sequencing Product Global Market Report 2026. - The market is estimated at $3.84 billion in 2026, up from $3.43 billion in 2025. - The report projects the market will reach $5.96 billion by 2030. - The company also says the market will expand at an 11.9% CAGR from 2025 to 2026 and an 11.6% CAGR from 2026 to 2030. - The report was published in London on Aug. 13, 2026.

The details: - Library preparation and target enrichment convert DNA or RNA samples into sequencing-ready formats. - The products selectively capture genomic regions of interest and improve sequencing library quality. - The report cites cancer genomics research, broader NGS adoption, targeted sequencing demand, biomarker studies and enrichment chemistry improvements as drivers of recent growth. - It points to precision diagnostics, clinical laboratory adoption, rare disease testing, better enrichment efficiency and supportive regulation as drivers through 2030. - The report expects wider use of targeted sequencing, more acceptance of enrichment kits, lower-cost sequencing solutions, broader clinical genomics testing and more customized panels. - North America held the largest market share in 2025. - Asia-Pacific is forecast to be the fastest-growing region over the coming years. - The report also covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The company says its 2026 reports include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based dashboards, market hotspots infographics, and key technology and future trend analysis. - The report offers a free sample and the full market report online: the sample report and the full report.

Between the lines: - The report frames personalized medicine as a major demand driver because FDA approvals for such treatments are rising. - In February 2024, the Personalized Medicine Coalition said the FDA approved 26 new personalized medicines in 2023, up from 12 in 2022. - That trend suggests more clinical use of genomics tools that depend on library prep and enrichment products. - North America's lead appears linked to stronger healthcare infrastructure, deeper genomics research and regulatory support. - Asia-Pacific's growth outlook reflects expanding clinical genomics capacity, biotech investment and wider healthcare access.

What's next: - Demand is likely to keep rising as clinical laboratories expand NGS use and more diseases are tested with genomic tools. - Companies are expected to keep investing in enrichment chemistry, sequencing technologies and customized panels. - The market's growth path points to continued competition around cost, efficiency and clinical utility.

The bottom line: - Library prep and target enrichment are moving from specialized research tools to core infrastructure for precision genomics, and the market is on track for steady double-digit growth through 2030.